Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Coagulation

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Influence of sampling satisfaction using endometrial sampling device and related factors for pathology diagnostic accordance rate].

Zhonghua fu chan ke za zhi·2014

Same author

Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.

Hepatobiliary & pancreatic diseases international : HBPD INT·2014

Same author

Mechanisms of human erythrocytic bioactivation of nitrite.

The Journal of biological chemistry·2014

Same author

Simulation research on the natural degradation process of PBDEs in soil polluted by e-waste under increased concentrations of atmospheric O(3).

Chemosphere·2014

Same author

Two-dimensional colloidal crystal assisted formation of conductive porous gold films with flexible structural controllability.

Journal of colloid and interface science·2014

Same author

REDD1 attenuates cardiac hypertrophy via enhancing autophagy.

Biochemical and biophysical research communications·2014

Search research articles

Related Experiment Video

Updated: Oct 23, 2025

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

Human coagulation factor IX: a systematic review of its characteristics.

Ru Yin¹, Chen Liu

¹Guang Dong Shuang Lin Bio-pharmacy Co., Ltd. Zhanjiang City, Guangdong Province, China.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis

|August 19, 2021

Summary

Human coagulation factor IX (FIX) is crucial for blood clotting and treating haemophilia B. This review details FIX function, haemophilia B

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Related Experiment Videos

Last Updated: Oct 23, 2025

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Area of Science:

Biochemistry
Hematology
Molecular Biology

Background:

Human coagulation factor IX (FIX) is a vitamin K-dependent glycoprotein essential for the blood coagulation cascade.
Factor IX deficiency leads to haemophilia B, a bleeding disorder.
Understanding FIX is critical for developing effective haemophilia B therapies.

Purpose of the Study:

To elucidate the role of coagulation factor IX in the coagulation process.
To explain the molecular basis of haemophilia B.
To provide a comprehensive overview of FIX, including its history, purification, clinical use, and future prospects.

Main Methods:

Sequence analysis of human coagulation factor IX using the NCBI's EST database.
Literature review on the development history, isolation, and purification of FIX.
Compilation of clinical indications and complications associated with FIX therapy.

Main Results:

Sequence analysis aided in predicting FIX structure and understanding its functional basis.
The historical development and purification processes of FIX were summarized.
Clinical aspects, including indications and complications of FIX, were detailed.

Conclusions:

A comprehensive understanding of FIX characteristics is vital for readers.
The study provides insights into the molecular biology and therapeutic applications of FIX.
Future directions for FIX product development are discussed.